Bolt Biotherapeutics (BOLT) Q2 2026 Earnings

12MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-7.1
-5.68
-4.27
-2.85

Details

Expected EPS
-2.85
Actual EPS
-4.31
Surprise EPS
-1.46
Surprise Percent
+51.23%

Description

Bolt Biotherapeutics (BOLT) has reported earnings of -4.31 per share for Q2 2026.

0 Comments

Share your thoughts